159 related articles for article (PubMed ID: 24289857)
21. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.
Gelbard M; Hellstrom WJ; McMahon CG; Levine LA; Smith T; Tursi J; Kaufman G; Goldstein I
J Sex Med; 2013 Nov; 10(11):2822-31. PubMed ID: 24112401
[TBL] [Abstract][Full Text] [Related]
22. Collagenase Clostridium Histolyticum for the Treatment of Peyronie's Disease: A 'Real World' Clinical Perspective.
Anaissie J; Hellstrom WJ; Yafi FA
Drugs; 2016 Oct; 76(16):1523-1528. PubMed ID: 27770352
[TBL] [Abstract][Full Text] [Related]
23. [Collagenase Clostridum histolyticum in the management of Dupuytren's contracture].
Holzer LA; Holzer G
Handchir Mikrochir Plast Chir; 2011 Oct; 43(5):269-74. PubMed ID: 21935843
[TBL] [Abstract][Full Text] [Related]
24. Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact.
Gabrielson AT; Spitz JT; Hellstrom WJG
Sex Med Rev; 2018 Jan; 6(1):143-156. PubMed ID: 28454897
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD).
Carson CC; Sadeghi-Nejad H; Tursi JP; Smith TM; Kaufman GJ; Gilbert K; Honig SC
BJU Int; 2015 Nov; 116(5):815-22. PubMed ID: 25818264
[TBL] [Abstract][Full Text] [Related]
26. Clostridium histolyticum collagenase - is this a revolutionary medical treatment for Peyronie's disease?
Poullis C; Shabbir M; Eardley I; Mulhall J; Minhas S
BJU Int; 2016 Aug; 118(2):186-9. PubMed ID: 26683137
[No Abstract] [Full Text] [Related]
27. Collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture.
Kaplan FT
Drugs Today (Barc); 2011 Sep; 47(9):653-67. PubMed ID: 21971540
[TBL] [Abstract][Full Text] [Related]
28. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
Gilpin D; Coleman S; Hall S; Houston A; Karrasch J; Jones N
J Hand Surg Am; 2010 Dec; 35(12):2027-38.e1. PubMed ID: 21134613
[TBL] [Abstract][Full Text] [Related]
29. Letter Regarding "Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium Histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data".
Holzer LA
J Hand Surg Am; 2015 Nov; 40(11):2317. PubMed ID: 26518325
[No Abstract] [Full Text] [Related]
30. Intralesional Injection of Collagenase Clostridium histolyticum May Increase the Risk of Late-Onset Penile Fracture.
Beilan JA; Wallen JJ; Baumgarten AS; Morgan KN; Parker JL; Carrion RE
Sex Med Rev; 2018 Apr; 6(2):272-278. PubMed ID: 28923562
[TBL] [Abstract][Full Text] [Related]
31. Collagenase clostridium histolyticum: a novel medical treatment for Peyronie's disease.
Abdel Raheem A; Johnson M; Ralph D; Garaffa G
Minerva Urol Nefrol; 2018 Aug; 70(4):380-385. PubMed ID: 29761688
[TBL] [Abstract][Full Text] [Related]
32. Re: Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.
Dincer M; Serefoglu EC
J Sex Med; 2014 May; 11(5):1350. PubMed ID: 24602117
[No Abstract] [Full Text] [Related]
33. Re: Patient Perspectives on Peyronie's Disease: Results of Poststudy Interviews from a Phase 2 Trial of Collagenase Clostridium histolyticum.
Seftel AD
J Urol; 2019 Apr; 201(4):649. PubMed ID: 30653023
[No Abstract] [Full Text] [Related]
34. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Badalamente MA; Hurst LC; Benhaim P; Cohen BM
J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
[TBL] [Abstract][Full Text] [Related]
35. The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study.
Gaston RG; Larsen SE; Pess GM; Coleman S; Dean B; Cohen BM; Kaufman GJ; Tursi JP; Hurst LC
J Hand Surg Am; 2015 Oct; 40(10):1963-71. PubMed ID: 26216077
[TBL] [Abstract][Full Text] [Related]
36. Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease.
Tsambarlis P; Levine LA
Int J Impot Res; 2020 Mar; 32(2):257-258. PubMed ID: 31417157
[No Abstract] [Full Text] [Related]
37. Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease.
Masterson T; Patel P; Ramasamy R
Int J Impot Res; 2020 Mar; 32(2):251-252. PubMed ID: 30745568
[No Abstract] [Full Text] [Related]
38. Re: Surgical Correction of Persistent Peyronie's Disease following Collagenase Clostridium histolyticum Treatment.
Morey AF
J Urol; 2015 Sep; 194(3):761. PubMed ID: 26292883
[No Abstract] [Full Text] [Related]
39. Successful Treatment of Residual Curvature in Peyronie Disease in Men Previously Treated With Intralesional Collagenase Clostridium Histolyticum.
DeLay K; Diao L; Nguyen HMT; Zurawin J; Libby R; Yafi F; Hellstrom WJG
Urology; 2017 Dec; 110():110-113. PubMed ID: 28886994
[TBL] [Abstract][Full Text] [Related]
40. More tips for collagenase injections.
Denkler K
J Hand Surg Am; 2014 Oct; 39(10):2120-1. PubMed ID: 25257494
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
